Guinness World RecordsDATRI Celebrates World Marrow Donor Day – 50 Participants …PR Newswire India (press release)DATRI Blood Stem Cell Donors Registry celebrated the World Marrow Donor Day on 17th September across India. The primary purpose of the c…
T-Guard trial doses final patient with acute graft-versus-host diseaseEuropean Pharmaceutical Review… and have a poor long-term prognosis with severe morbidity and high mortality rates. This number is expected to grow substantially as the number of p…
DATRI and Narayana Health Celebrate World Marrow Donor Day to Spread Awareness on Blood Stem Cell DonationPR Newswire India (press release)The need to raise awareness on blood stem cell donation and registering as willing donors in the country is urgen…
Oxfordshire Guardian |
One-in-a-million plea for donor to save ill toddler
Oxfordshire Guardian The tot is in London’s Great Ormond Street Children’s Hospital undergoing experimental treatment, but his best hope is a stem cell transplant from an unrelated donor, which would replace his faulty immune system with a healthy one. Mr and Mrs Kim, who … |
Herald liveUrgent call for bone marrow donors – HeraldLIVEHerald liveEvery year hundreds of South Africans with blood diseases such as leukaemia and bone marrow failure reach a stage where their only chance of survival is to.and more »
Memorial Sloan Kettering Cancer Center (blog)The Mighty Finn: A Transplant Success StoryMemorial Sloan Kettering Cancer Center (blog)Fortunately, by the time Finn was born, advances in medicine had made it possible for patients with this rare disorder …
News Today |
Bone marrow donors share their experience
News Today However studies have shown that donors below the age of 45 years have lesser complications and are more effective for the recipients. Unrelated donors need to be healthy individuals between the age of 18 to 50 years.’ Datri co-founder Raghu Rajagopal … |
OncoBreak: Genetic Test Costs; Take a Break from Cancer; Cord Blood BetterMedPage TodayUsing umbilical cord blood for stem-cell transplants led to improved survival in leukemia as compared with stem cells obtained from unrelated donors. (Fred Hutchinso…
Lymphoma News Today |
Clevecord, Umbilical Cord Blood Product for HSCT in Lymphoma Patients, Approved by FDA
Lymphoma News Today The U.S. Food and Drug Administration (FDA) has approved Cleveland Cord Blood Center’s Clevecord use in hematopoietic stem cell transplants from unrelated donors in patients with leukemia, lymphoma, and immune system disorders and other … |
Xenikos BV: Last patient treated in Phase 1/2 trial with T-Guard(TM) in acute graft-versus-host diseaseYahoo Finance UKNijmegen, the Netherlands, September 15, 2016 – Xenikos B.V., focused on the development of innovative immunotherapies for the treatm…